New diabetes drug enters early human safety tests
NCT ID NCT07570992
First seen May 09, 2026 · Last updated May 26, 2026 · Updated 4 times
Summary
This early-stage study tests a new experimental medicine called NNC1679-0001 for type 2 diabetes. About 80 healthy volunteers and people with type 2 diabetes will receive a single injection of either the study drug or a placebo. The main goal is to check if the drug is safe and how well the body handles it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Graz
RECRUITINGGraz, 8010, Austria
Conditions
Explore the condition pages connected to this study.